Miclacam Capsule (Cefaclor Hydrate)

Adult dose

As cefaclor hydrate, 250 mg (potency) should be taken orally every 8 hours. For severe infections (such as pneumonia) and infections with reduced susceptibility, it can be administered at double the dosage. In the case of acute gonococcal urethritis, this drug 3 g may be administered in a single dose combined with probenecid 1 g.

Child dose

Administer 20 mg (potency) per kg of body weight divided into doses every 8 hours. In cases of severe infections, otitis media, or infections with reduced susceptibility, 40 mg (potency) per kg of body weight may be administered daily, with a maximum dose of

This drug works by binding to specific proteins and disrupting bacterial cell wall synthesis, effectively killing bacteria. This drug should not be used in patients who have experienced severe allergic reactions or shock due to this drug or other antibiotics in the same class in the past. Additionally, since it contains lactose, it should not be administered to patients with lactose intolerance or certain genetic metabolic disorders. Patients with allergies to penicillin antibiotics or a family history of such allergies, those with severe renal dysfunction, and patients with a history of gastrointestinal disorders should use this drug with increased caution. This drug can occasionally cause serious allergic reactions, skin rashes, blood abnormalities, liver and kidney function disorders, gastrointestinal problems, and central nervous system symptoms. If any unusual symptoms occur while using this drug, the patient should contact healthcare providers immediately. Moreover, prolonged or unnecessary use of this drug can lead to antibiotic resistance, so it is important to confirm sensitivity to the infection-causing bacteria and use it only for the necessary duration. Drug interactions may occur when taken with other medications, especially if the patient is taking drugs that affect the kidneys, anticoagulants, or oral contraceptives. Patients should inform their doctor or pharmacist in such cases. The safety of this drug has not been established in pregnant or breastfeeding women, so it should only be used after careful consideration of the benefits and risks of treatment. It is recommended not to use this drug in neonates under 1 month of age, as safety and efficacy have not been confirmed. Elderly patients may experience more side effects due to decreased physiological function, so it is important to adjust the dosage and administration intervals and use it cautiously. While using this drug, it may affect the results of urine tests or blood tests, so patients should inform their healthcare provider about this during examinations.

Serious side effects

Shock (severe allergic reaction), anaphylactic symptoms (including difficulty breathing), hives, Stevens-Johnson syndrome, toxic epidermal necrolysis, liver abnormalities (including jaundice), acute renal failure, severe colitis (pseudomembranous colitis), dyspnea, interstitial pneumonia, eosinophilic pulmonary infiltrates, serious neurological symptoms (including seizures)

Mild side effects

• Generalized flushing
• vascular edema
• sensory disturbances
• syncope
• hypertension
• vasodilation
• rash
• erythema
• itching
• fever

This drug may be sensitive to light, so it should be stored in an opaque container that does not allow light in. Additionally, when storing the drug, avoid extremely hot or cold places, and it is advisable to keep it at normal room temperature.

Appearance

A hard capsule with a purple upper and lower part filled with light yellow powder

Package unit

30 capsules/bottle, 100 capsules/bottle